Welcome to Heart Health Care, LLC

Information from Recent Presentations

19th Southwestern Regional Annual
Nurse Practitioner Clinical Symposium

July 27 - 29 2007
Scottsdale Plaza Resort

Handout materials are available here (211Kb).

PowerPoint slides materials from the full presentation are available here (119 slides: 7.3Mb).

If you have trouble downloading the complete file, try downloading it in pieces here:

1. Part 1 (slides 1-40: 772Kb).
2. Part 2 (slides 41-79: 1.84Mb).
3. Part 3 (slides 80-91 3.11Mb).
4. Part 4 (slides 92-119 3.21Mb).

* To view these materials in PDF format, you will need the FREE Adobe Acrobat Reader,
available here:

Northern Arizona Heart Consultants
2nd Annual Cardiology Update
Heart Failure... Medical Management
August 7, 2004

Sponsored by AstraZenca

Information enabling the participants to:

1. Describe the new staging of Heart Failure.
2. Describe the pharmaceutical management of heart failure including titration and management of therapy complications.
3. Discuss the expanding role of natriuretic peptides in the management of heart failure.
4. Discuss the role of the CHF clinic.

Additional materials from this presentation are available here.

Northern Arizona Heart Consultants
Update on Dyslipidemia
August 6, 2004

Sponsored by AstraZenca

Information enabling the participants to:

1. Apply the ATP III guidelines to specific patient profiles.
2. Describe the recent updates to the ATP III.
3. Select the appropriate lipid-lowering agent (LLA) for the lipid abnormality.
4. Describe the indications and monitoring for combination therapy.
5. Describe the benefits of statin therapy beyond lowering of cholesterol.

Additional materials from this presentation are available here.

29th Nurse Practitioner Symposium
July 15-18, 2004
Keystone, Colorado

Update on Dyslipidemia Rx LE
Industry Sponsored Symposium
July 16th

Recognize how to select the appropriate lipid-lowering agent (LLA) or agents for lipid abnormalities; steps for using combination therapy to avoid adverse outcomes; and the use of LLA in the elderly, women and children. Case studies will be used throughout the program. Audience participation is encouraged; bring your difficult lipid profiles.

Additional materials from this presentation are available here.